Brown & Brown Q3 2026 slides: growth continues amid margin pressure
Brown & Brown (BRO) reported Q3 2026 revenue of $1.7B, up 7.4% YoY, but missed earnings estimates. Shares fell 4.28%. Organic growth slowed to 1.2%, and margins compressed. The company raised 2026 synergy targets from Accession acquisition to $50M and increased its 2028 run-rate target to $175M. Retail segment grew 2.6% organically, while Specialty Distribution declined 0.8%.
How this was made
The 30-second read
Why it matters
The earnings miss triggered a 4.28% share decline, highlighting investor sensitivity to margin trends.
Market read
First release of Q3 earnings; price reaction provides immediate trading opportunity.
What to watch
Strong cash flow and dividend increase could support price stability despite short-term miss.
Background
Brown & Brown reported Q3 2026 results with revenue growth but margin compression and a slight earnings miss.
Ticker impact
Shares fell 4.28% to $68.04 after the Q3 2026 earnings miss and margin compression.
downward pressure as investors price in lower margins and revenue shortfall
Adjusted EPS of $1.07 missed estimates by $0.02 and revenue was $40M below forecast, prompting a sell-off.
Market effects
Insurance brokerage sector may see broader pressure from margin compression trends.
U.S. market sentiment may dip slightly as a mid-cap insurer underperforms.
Limited global impact; primarily affects U.S. insurance brokerage equities.
Counterpoint
Buy on dip if synergy gains from Accession integration materialize faster than expected.
Key entities
- CompanyBrown & Brown
U.S. insurance brokerage reporting Q3 2026 earnings.




